Home  |  Contact

Cellosaurus OPM-2/BTZ (CVCL_4V72)

[Text version]

Cell line name OPM-2/BTZ
Synonyms OPM2/BTZ
Accession CVCL_4V72
Resource Identification Initiative To cite this cell line use: OPM-2/BTZ (RRID:CVCL_4V72)
Comments Characteristics: Produces Ig lambda.
Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).
Derived from sampling site: Peripheral blood.
Sequence variations Heterozygous for CDKN2A p.His83Tyr (c.247C>T) (from parent cell line).
Heterozygous for FGFR3 p.Lys650Glu (c.1948A>G) (from parent cell line).
Heterozygous for SMAD2 p.Leu87Arg (c.260T>G) (from parent cell line).
Homozygous for TP53 p.Arg175His (c.524G>A) (from parent cell line).
Disease Plasma cell myeloma (NCIt: C3242)
Multiple myeloma (ORDO: Orphanet_29073)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1625 (OPM-2)
Sex of cell Female
Age at sampling 56Y
Category Cancer cell line
Publications

PubMed=20555361; DOI=10.1038/leu.2010.137
Ri M., Iida S., Nakashima T., Miyazaki H., Mori F., Ito A., Inagaki A., Kusumoto S., Ishida T., Komatsu H., Shiotsu Y., Ueda R.
Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress.
Leukemia 24:1506-1512(2010)

Cross-references
Other Wikidata; Q54936484
Entry history
Entry creation14-Dec-2015
Last entry updated12-Mar-2020
Version number6